PLCS Trademark

Trademark Overview

On Wednesday, January 22, 2020, a trademark application was filed for PLCS with the United States Patent and Trademark Office. The USPTO has given the PLCS trademark a serial number of 88768567. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, October 10, 2023. This trademark is owned by Platelet BioGenesis Inc.. The PLCS trademark is filed in the Pharmaceutical Products category with the following description:

Platelet variants for scientific and medical research; platelet variants for medical or clinical use; pharmaceutical compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory and immune diseases, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; pharmaceutical compositions comprising platelet variants for transfusion in oncology, trauma and surgery; platelet variants for delivering proteins, antibodies, nucleic acids and other drugs to tumors, sites of vascular injury and inflammation, immune-oncology, hematology , cardiovascular, inflammatory and immune diseases, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; platelet variants for the treatment of tumors, immune-oncology, hematology , cardiovascular, inflammatory and immune diseases, critical care...
plcs

General Information

Serial Number88768567
Word MarkPLCS
Filing DateWednesday, January 22, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, October 10, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 9, 2021

Trademark Statements

Goods and ServicesPlatelet variants for scientific and medical research; platelet variants for medical or clinical use; pharmaceutical compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory and immune diseases, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; pharmaceutical compositions comprising platelet variants for transfusion in oncology, trauma and surgery; platelet variants for delivering proteins, antibodies, nucleic acids and other drugs to tumors, sites of vascular injury and inflammation, immune-oncology, hematology , cardiovascular, inflammatory and immune diseases, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; platelet variants for the treatment of tumors, immune-oncology, hematology , cardiovascular, inflammatory and immune diseases, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; platelet variants as source for growth factors for medical or clinical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 25, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePlatelet BioGenesis Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NamePlatelet BioGenesis Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Wednesday, October 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 10, 2023SOU EXTENSION 5 GRANTED
Friday, October 6, 2023SOU EXTENSION 5 FILED
Friday, October 6, 2023SOU TEAS EXTENSION RECEIVED
Saturday, July 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 14, 2023SOU EXTENSION 4 GRANTED
Thursday, April 6, 2023SOU EXTENSION 4 FILED
Tuesday, July 11, 2023NOTICE OF REVIVAL - E-MAILED
Monday, July 10, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, July 10, 2023PETITION TO REVIVE-GRANTED
Monday, July 10, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, May 8, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 8, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 17, 2022SOU EXTENSION 3 GRANTED
Thursday, October 6, 2022SOU EXTENSION 3 FILED
Friday, October 14, 2022NOTICE OF REVIVAL - E-MAILED
Thursday, October 13, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, October 13, 2022PETITION TO REVIVE-GRANTED
Thursday, October 13, 2022TEAS PETITION TO REVIVE RECEIVED
Tuesday, April 26, 2022CORRECTED NOA E-MAILED
Monday, April 25, 2022NOTICE OF ALLOWANCE CORRECTION ENTERED
Friday, April 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 6, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, April 6, 2022SOU EXTENSION 2 GRANTED
Wednesday, April 6, 2022SOU EXTENSION 2 FILED
Wednesday, April 6, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, April 6, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 6, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 6, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 12, 2021SOU EXTENSION 1 GRANTED
Tuesday, October 5, 2021SOU EXTENSION 1 FILED
Tuesday, October 12, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 5, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 6, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 4, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 4, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 5, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 5, 2020NON-FINAL ACTION E-MAILED
Friday, June 5, 2020NON-FINAL ACTION WRITTEN
Friday, May 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 17, 2020NON-FINAL ACTION E-MAILED
Friday, April 17, 2020NON-FINAL ACTION WRITTEN
Friday, April 10, 2020ASSIGNED TO EXAMINER
Saturday, January 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 25, 2020NEW APPLICATION ENTERED

Related Keywords

plcs immune platelet variants oncology disorders hematology cardiovascular diseases care critical